Gold | Use of Relationship Marketing of 2018 – Medical Marketing and Media

0
9

Medical Marketing and Media

Gold | Use of Relationship Marketing of 2018
Medical Marketing and Media
Xeljanz was the first JAK inhibitor approved in the U.S. for rheumatoid arthritis. It was the first new drug in the category in more than 10 years, and it represented a new class of treatment. Wunderman Health introduced the drug and helped drive

LEAVE A REPLY